Jod-Basedow phenomenon

<h2 id="pathophysiology">Pathophysiology</h2>
<p>This phenomenon is thus iodine-induced <a href="/facts/Hyperthyroidism/H9Eqmbgk">hyperthyroidism</a>, typically presenting in a patient with <a href="/facts/Endemic_(epidemiology)/YXHcRrQX">endemic</a> <a href="/facts/Goiter/0kNGMcb6">goiter</a> (due to <a href="/facts/Iodine_deficiency/NsTLf3E5">iodine deficiency</a>), who relocates to an iodine-abundant geographical area. People who have <a href="/facts/Graves_disease/6CjnWNdE">Graves disease</a>, <a href="/facts/Toxic_multinodular_goiter/o46Pxte0">toxic multinodular goiter</a>, or various types of <a href="/facts/Thyroid_adenoma/HcT47aYe">thyroid adenoma</a> are also at risk of the Jod-Basedow effect when receiving iodine, because the thyroid will then not respond to the negative feedback from increased <a href="/facts/Thyroid_hormone/9k4xJtCq">thyroid hormones</a>. The source of iodine may be from the diet, administration of <a href="/facts/Iodinated_contrast/WCkoRRyE">iodinated contrast</a> for medical imaging, or <a href="/facts/Amiodarone_induced_thyrotoxicosis/K94ArawC">amiodarone</a> (an <a href="/facts/Antiarrhythmic/RJPHtxKr">antiarrhythmic</a> drug).
</p><p>The hyperthyroidism usually develops over 2 to 12 weeks following iodine administration.<a class="footnote-ref" id="fnref:2" href="#fn:2"><sup>2</sup></a>
</p><p>In some ways the Jod-Basedow phenomenon is the opposite of two physiological compensation mechanisms, the <a href="/facts/Plummer_effect/XDzGuJjn">Plummer effect</a> and the <a href="/facts/Wolff%25E2%2580%2593Chaikoff_effect/F540kunz">Wolff–Chaikoff effect</a>, which in normal persons and in persons with thyroid disease, suppress the thyroid hormone after ingestion of large quantities of iodine or iodide. However, unlike the Plummer and Wolff-Chaikoff effects, the Jod-Basedow effect does not occur in persons with normal thyroid glands, as thyroid hormone synthesis and release in normal persons is controlled by pituitary TSH secretion, which does not allow hyperthyroidism when extra iodine is ingested.
</p>
<h2 id="precautions-in-medical-imaging">Precautions in medical imaging</h2>
<p>In <a href="/facts/Iodinated_contrast/WCkoRRyE">iodinated contrast</a> administration for medical imaging, monitoring is indicated in people with <a href="/facts/Thyroid_disease/51xH3TXu">thyroid disease</a>, such as <a href="/facts/Toxic_multinodular_goiter/o46Pxte0">toxic multinodular goiter</a>, <a href="/facts/Graves%2527_disease/6CjnWNdE">Graves' disease</a>, or <a href="/facts/Hashimoto%2527s_thyroiditis/myBntJv5">Hashimoto's thyroiditis</a>.<a class="footnote-ref" id="fnref:3" href="#fn:3"><sup>3</sup></a> Otherwise, for the general population, routine screening with thyroid function tests is generally not feasible.<a class="footnote-ref" id="fnref:4" href="#fn:4"><sup>4</sup></a>
</p>
<h2 id="history-and-nomenclature">History and nomenclature</h2>
<p>The Jod-Basedow effect is named for the German word for iodine, <i>Jod</i> (all nouns are capitalized in German), plus the name of <a href="/facts/Karl_Adolph_von_Basedow/u21GI8Jo">Karl Adolph von Basedow</a>, a German physician who first described the effect. The nomenclature "Jod-Basedow" was carried over intact from German, rather than being translated.
</p><p>The Jod-Basedow phenomenon is differentiated from <a href="/facts/Basedow%2527s_disease/6CjnWNdE">Basedow's disease</a>, which is occasionally used as a synonym for <a href="/facts/Graves%2527_disease/6CjnWNdE">Graves' disease</a>.
</p>

<h2 id="references">References</h2>

<ol>
<li id="fn:1"><p>El-Shirbiny AM, Stavrou SS, Dnistrian A, Sonenberg M, Larson SM, Divgi CR (November 1997). "Jod-Basedow syndrome following oral iodine and radioiodinated-antibody administration". J. Nucl. Med. 38 (11): 1816–7. PMID 9374363. <a href="http://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=9374363" target="_blank">http://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=9374363</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li>
<li id="fn:2"><p>Dunne P, Kaimal N, MacDonald J, Syed AA (2013). "Iodinated contrast-induced thyrotoxicosis". CMAJ. 185 (2): 144–7. doi:10.1503/cmaj.120734. PMC 3563887. PMID 23148056. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563887" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563887</a> <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li>
<li id="fn:3"><p>Yıldız, Sema; Kuşkonmaz, Şerife Mehlika (2016). "Effect of iodinated contrast media on thyroid: a brief review". Journal of Health Sciences. 6 (1): 12. doi:10.17532/jhsci.2016.278. ISSN 1986-8049. <a href="https://doi.org/10.17532%2Fjhsci.2016.278" target="_blank">https://doi.org/10.17532%2Fjhsci.2016.278</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li>
<li id="fn:4"><p>Yıldız, Sema; Kuşkonmaz, Şerife Mehlika (2016). "Effect of iodinated contrast media on thyroid: a brief review". Journal of Health Sciences. 6 (1): 12. doi:10.17532/jhsci.2016.278. ISSN 1986-8049. <a href="https://doi.org/10.17532%2Fjhsci.2016.278" target="_blank">https://doi.org/10.17532%2Fjhsci.2016.278</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li>
</ol>

Jod-Basedow phenomenon open-in-new

Jod-Basedow phenomenon